$580 Billion is the total value of ORACLE INVESTMENT MANAGEMENT INC's 25 reported holdings in Q2 2013. The portfolio turnover from Q1 2013 to Q2 2013 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QDEL | New | QUIDEL CORP | $83,367,117,000 | – | 3,265,457 | +100.0% | 14.38% | – |
| THC | New | TENET HEALTHCARE CORP | $82,090,270,000 | – | 1,780,700 | +100.0% | 14.16% | – |
| ACOR | New | ACORDA THERAPEUTICS INC | $65,863,479,000 | – | 1,996,468 | +100.0% | 11.36% | – |
| THOR | New | THORATEC CORP | $59,643,953,000 | – | 1,904,949 | +100.0% | 10.29% | – |
| OPK | New | OPKO HEALTH INC | $41,277,568,000 | – | 5,813,742 | +100.0% | 7.12% | – |
| NXTM | New | NXSTAGE MEDICAL INC | $35,161,830,000 | – | 2,462,313 | +100.0% | 6.06% | – |
| AXK | New | ACCELR8 TECHNOLOGY INC | $33,614,835,000 | – | 4,139,758 | +100.0% | 5.80% | – |
| MZOR | New | MAZOR ROBOTICS LTDsponsored ads | $26,897,456,000 | – | 1,880,941 | +100.0% | 4.64% | – |
| GTXI | New | GTX INC DEL | $26,532,019,000 | – | 4,020,003 | +100.0% | 4.58% | – |
| TSRO | New | TESARO INC | $22,168,647,000 | – | 677,112 | +100.0% | 3.82% | – |
| ARAY | New | ACCURAY INC | $16,464,759,000 | – | 2,868,425 | +100.0% | 2.84% | – |
| GTIV | New | GENTIVA HEALTH SERVICES INC | $15,760,883,000 | – | 1,582,418 | +100.0% | 2.72% | – |
| HNSN | New | HANSEN MEDICAL INC | $11,932,909,000 | – | 8,315,616 | +100.0% | 2.06% | – |
| TTHI | New | TRANSITION THERAPEUTICS INC | $11,620,250,000 | – | 3,586,497 | +100.0% | 2.00% | – |
| MAKO | New | MAKO SURGICAL CORP | $11,489,832,000 | – | 953,513 | +100.0% | 1.98% | – |
| IRWD | New | IRONWOOD PHARMACEUTICALS INC | $10,993,324,000 | – | 1,107,082 | +100.0% | 1.90% | – |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $4,963,071,000 | – | 1,961,688 | +100.0% | 0.86% | – |
| AGEN | New | AGENUS INC | $4,645,160,000 | – | 1,225,636 | +100.0% | 0.80% | – |
| WBMD | New | WEBMD HEALTH CORP | $4,320,679,000 | – | 147,112 | +100.0% | 0.74% | – |
| VRML | New | VERMILLION INC | $4,087,971,000 | – | 2,799,980 | +100.0% | 0.70% | – |
| BIIB | New | BIOGEN IDEC INC | $2,496,966,000 | – | 11,603 | +100.0% | 0.43% | – |
| MBLX | New | METABOLIX INC | $2,354,539,000 | – | 1,658,126 | +100.0% | 0.41% | – |
| AVEO | New | AVEO PHARMACEUTICALS INC | $1,437,500,000 | – | 575,000 | +100.0% | 0.25% | – |
| MNKD | New | MANNKIND CORP | $356,071,000 | – | 54,738 | +100.0% | 0.06% | – |
| LTS | New | LADENBURG THALMAN FIN SVCS I | $275,301,000 | – | 166,849 | +100.0% | 0.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
| BIOGEN INC | 42 | Q3 2023 | 0.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 25 | Q3 2023 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.